|Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.|
|PMID: 23545506 Owner: NLM Status: MEDLINE|
|BACKGROUND: This study reviewed the outcomes of a screening protocol for BK viremia to determine if early diagnosis, followed by immunosuppression minimization, would prevent progression to nephropathy and graft loss.
METHODS: This review included 369 renal transplant recipients tested for BK virus at serial time points after transplantation. Management included immunosuppression minimization plus cidofovir treatment for BK nephropathy.
RESULTS: Recipients received tacrolimus-based immunosuppression, with 8% prednisone-free and 6% who received desensitization. With a mean follow-up of 22 ± 10 months, 16% (n = 57) of recipients became BK viremia positive. The median (range) time to diagnosis was 3 (1-17) months. Because renal biopsy was performed selectively, 59% of recipients underwent biopsy, with 47% showing BK nephropathy. Seventy-four percent of recipients cleared the virus at a median (range) time of 9 (3-33) months, with four grafts lost to BK nephropathy. Cidofovir-treated recipients displayed a higher viral load at diagnosis but showed equivalent renal function at last evaluation. In multivariate analysis, recipient age, Asian ethnicity, deceased donor, and prednisone use were factors independently associated with BK viremia. Actuarial survival of BK-positive grafts was worse than that of BK-negative grafts (P<0.01, log-rank test). At 9 and 12 months, the mean estimated glomerular filtration rate of the BK-positive group was lower than that of the BK-negative cohort (P = 0.02).
CONCLUSIONS: Despite using a screening protocol combined with immunosuppression minimization, BK-positive recipients had a greater risk of graft loss and impaired function than recipients free of infection. Future investigations should focus on practices to prevent BK viremia.
|Richard J Knight; Lillian W Gaber; Samir J Patel; Jennifer M DeVos; Linda W Moore; A Osama Gaber|
Related Documents :
|23117686 - Calyceal fistula: a problematic, but treatable, complication of renal transplantation.
23664606 - Metastatic squamous cell carcinoma in a bone marrow transplant recipient.
24825516 - Clinicopathological characteristics and effect of late acute rejection on renal transpl...
23452876 - Small solid renal masses: characterization by diffusion-weighted mri at 3 t.
10762216 - Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantati...
17520726 - Magnetic resonance cholangiography of biliary strictures after liver transplantation: a...
|Type: Journal Article|
|Title: Transplantation Volume: 95 ISSN: 1534-6080 ISO Abbreviation: Transplantation Publication Date: 2013 Apr|
|Created Date: 2013-04-02 Completed Date: 2013-07-08 Revised Date: 2013-11-18|
Medline Journal Info:
|Nlm Unique ID: 0132144 Medline TA: Transplantation Country: United States|
|Languages: eng Pagination: 949-54 Citation Subset: IM|
|Department of Surgery, The Methodist Hospital, Houston, TX 77030, USA. firstname.lastname@example.org|
|APA/MLA Format Download EndNote Download BibTex|
Antiviral Agents / therapeutic use
BK Virus / genetics, isolation & purification*
Cytosine / analogs & derivatives, therapeutic use
Glomerular Filtration Rate
Immunosuppressive Agents / adverse effects*
Kidney Diseases / diagnosis, immunology, prevention & control*, virology
Kidney Transplantation / adverse effects, immunology*
Mass Screening* / methods
Organophosphonates / therapeutic use
Polyomavirus Infections / diagnosis*, immunology, virology
Predictive Value of Tests
Tumor Virus Infections / diagnosis*, immunology, virology
Viremia / diagnosis*, immunology, virology
|0/Antiviral Agents; 0/Immunosuppressive Agents; 0/Organophosphonates; 71-30-7/Cytosine; JIL713Q00N/cidofovir|
Transplantation. 2013 Oct 15;96(7):e50
Transplantation. 2013 Oct 15;96(7):e51 [PMID: 24100844 ]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T...
Next Document: Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and...